While the timeline for bringing drugs to market has not shortened in the past 30 years, Citeline VP Claire Riches says AI has the potential to change that.
I still very much believe that the pharma industry, how we bring drugs to market, is a people business: patients, healthcare professionals, people supporting running the trials.